October 30, 2026
3 min watch
NASHVILLE — In this video, Elliot Tapper, MD, FAASLD, discusses a presentation from the ACG Annual Meeting about when it is safe to stop cancer therapy when it results in hepatitis.
“While it might feel inelegant to simultaneously turbocharge someone’s immune system to attack their cancer while also try to cool it off to avoid hepatitis, these are the kinds of compromises that we make for the patients we see each and every day,” Tapper, professor of medicine at the University of Michigan, told Healio.
Sources/Disclosures
Source:
Thomas AS. Immunotherapy Hepatitis: When do you stop the cancer therapy? Presented at: the ACG Annual Scientific Meeting; Oct. 9-14, 2026; Nashville.
Disclosures:
Tapper reports no relevant financial disclosures.
Ask a clinical question and tap into Healio AI’s knowledge base.
- PubMed, enrolling/recruiting trials, guidelines
- Clinical Guidance, Healio CME, FDA news
- Healio’s exclusive daily news coverage of clinical data
